Core 3: Translational Pathology Shared Resource Core
Core 3: Translational Pathology Shared Resource Core
批准号:
10328042
负责人:
BEN H PARK
金额:
$2.79万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-09-21 至 2026-08-31
关键词:
AdvocacyAfrican AmericanAnatomyAntigensAwarenessBasic ScienceBioinformatics Shared ResourceBiological MarkersBiometryBiopsy SpecimenBloodCancer CenterCellsClinical TrialsCollaborationsCollectionCommunitiesConsultationsDNADevelopmentDoctor of PhilosophyFee-for-Service PlansFluorescenceFormalinFoundationsFutureGeneral HospitalsGenomicsGoalsHistologicHistologyHistopathologyHumanImmuneIn SituInstitutionMalignant NeoplasmsMedical ResearchMessenger RNAMinority GroupsMolecular BiologyMorphologyNormal tissue morphologyOperative Surgical ProceduresParaffin EmbeddingPathologyPilot ProjectsPopulationPopulation ResearchProcessProteomicsResearchResearch PersonnelResearch Project GrantsResource SharingRoleServicesSlideStainsTechniquesTechnologyTennesseeTimeTissue BanksTissue SampleTissuesTranslational ResearchUniversitiesWorkanimal tissueanticancer researchbasecancer health disparityclinical diagnosticsdesignhuman tissueimaging capabilitiesliquid biopsymedical schoolsmicroscopic imagingmolecular diagnosticsneoplasticoutreachrepositorytissue archivetissue processing
中文摘要
项目总结:翻译病理学共享资源核心
转化病理学共享资源核心(TPSRC)提供协作和收费服务支持
加强范德比尔特-英格拉姆梅哈里医学院(MMC)的基础和转化研究工作
癌症中心(VICC)和田纳西州立大学(大津)研究人员。TPSRC整合了人类
组织采集、组织学/免疫组织化学/组织病理学和形态学核心,位于中心位置
MMC将提供一整套不断扩展的高质量服务,包括人类癌症
研究组织库和分配,人类和动物组织处理,切片,常规和特殊
染色、基于免疫的细胞抗原染色、mRNA和DNA原位定位、组织学和
组织病理学审查和解释,以及各种最先进的成像能力。收集
用于相关研究和分子生物学研究的良好表征的人体组织是
癌症研究,是发展有效的转化医学研究的基础,
个性化的分子诊断和治疗。TPSRC与研究人员合作,
社区和设计,实施和验证新的核心方法和服务。为了促进融合
与生物统计学和生物信息学共享资源核心,MMC提供了一个校园办公室,为内部
为经常使用TPSRC的研究者提供咨询。与巨蟹座的合作
发挥宣传和教育作用的外联核心组织提高了对消除癌症研究工作的认识
非裔美国人和少数民族之间的差距。TPSRC将与人口研究中心密切合作,
和癌症公平临床试验(PRACTICE)共享资源核心,用于生物标本采集。进一步
TPSRC将积极参与由Josiah Ochieng博士提出的MVTCP赞助的研究项目,
(项目2)和Anil Shanker博士(试点项目)提供组织和病理学服务,以支持他们的
研究倡议。
英文摘要
PROJECT SUMMARY: TRANSLATIONAL PATHOLOGY SHARED RESOURCE CORE
The Translational Pathology Shared Resource Core (TPSRC) provides collaborative and fee-for service support
to enhance basic and translational research efforts for Meharry Medical College (MMC), Vanderbilt-Ingram
Cancer Center (VICC), and Tennessee State University (TSU) investigators. The TPSRC integrates the Human
Tissue Acquisition, Histology/Immunohistochemical/Histopathology, and Morphology Cores, centrally located at
MMC to provide a comprehensive suite of continually expanding high-quality services including human cancer
research tissue banking and distribution, human and animal tissue processing, sectioning, routine and special
staining, immune-based cell antigen staining, mRNA and DNA in-situ localization, histological and
histopathological review and interpretation, and a variety of state of the art imaging capabilities. The collection
of well-characterized human tissue for correlative research and molecular biology studies is a critical part of
cancer research and is the foundation for the development of effective translational medical research and
personalized molecular diagnostics and treatment. The TPSRC works collaboratively with the research
community and designs, implements, and validates new Core approaches and services. To facilitate integration
with the Biostatistics and Bioinformatics Shared Resource Core, MMC provides an on-campus office for in-house
consultation purposes for investigators who routinely utilize the TPSRC. Our collaboration with the Cancer
Outreach Core in an advocacy and educational role enhances awareness of research efforts to eliminate cancer
disparities in African American and minority groups. The TPSRC will work closely with the Population Research
And Clinical Trials In Cancer Equity (PRACTICE) Shared Resource Core for biospecimen collection. Further the
TPSRC will actively engage with the MVTCP–sponsored research projects proposed by Josiah Ochieng, PhD,
(Project 2) and Anil Shanker, PhD, (Pilot Project) to provide tissues and pathology services to support their
research initiatives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Complete Response in Blood as a Predictor for a Pathologic Complete Response after Neoadjuvant Therapy fo Breast Cancer
-
批准号:10380582
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2018
-
负责人:BEN H PARK
-
依托单位:
Molecular complete response in blood as a predictor for pathologic complete response after neoadjuvant therapy for breast cancer
-
批准号:9520587
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2018
-
负责人:BEN H PARK
-
依托单位:
Molecular Complete Response in Blood as a Predictor for a Pathologic Complete Response after Neoadjuvant Therapy fo Breast Cancer
-
批准号:10592440
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2018
-
负责人:BEN H PARK
-
依托单位:
Molecular Complete Response in Blood as a Predictor for a Pathologic Complete Response after Neoadjuvant Therapy fo Breast Cancer
-
批准号:9925755
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2018
-
负责人:BEN H PARK
-
依托单位:
Circulating plasma tumor DNA as a biomarker for early stage breast cancer
-
批准号:9392301
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2016
-
负责人:BEN H PARK
-
依托单位:
Core 3: Translational Pathology Shared Resource Core
-
批准号:10693374
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2011
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7036929
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7753761
-
项目类别:
-
资助金额:$6.12万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7537893
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7362430
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7745470
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7352000
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest
-
批准号:7174193
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest.
-
批准号:7535591
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2006
-
负责人:BEN H PARK
-
依托单位:
Genetic effectors of TGF-beta induced growth and arrest
-
批准号:7032632
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:BEN H PARK
-
依托单位:
SPORE in Breast Cancer
-
批准号:10456735
-
项目类别:
-
资助金额:$203.14万
-
财政年份:2003
-
负责人:BEN H PARK
-
依托单位:
SPORE in Breast Cancer
-
批准号:10704039
-
项目类别:
-
资助金额:$218.15万
-
财政年份:2003
-
负责人:BEN H PARK
-
依托单位:
Evaluation of Barriers to Completion of Breast Cancer Treatment at a Tertiary Teaching and Referral Center in Kenya
-
批准号:10623722
-
项目类别:
-
资助金额:$12.59万
-
财政年份:2003
-
负责人:BEN H PARK
-
依托单位:
SPORE in Breast Cancer
-
批准号:10226879
-
项目类别:
-
资助金额:$215.34万
-
财政年份:2003
-
负责人:BEN H PARK
-
依托单位:
Clinical and Pathologic Response to Neoadjuvant Chemotherapy for Breast Cancer
-
批准号:10845365
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2003
-
负责人:BEN H PARK
-
依托单位:
海外基金